The case for external collaboration in R&D is more substantial than most organizations treat it. Research on this topic spans high-tech manufacturing, pharmaceutical development, and large-scale cross-country firm surveys, and points in a consistent direction: companies that draw on outside knowledge sources outperform those that do not.

A 2022 study in the Journal of Innovation and Entrepreneurship, examining 195 high-tech firms, found that companies engaged in external collaboration produced an average of 8.01 new products compared to 5.20 among non-collaborative firms. A separate analysis of 84,919 firms across 14 European countries, published in MIT Sloan Management Review, found that organizations drawing on multiple external knowledge sources consistently outperformed those relying on fewer, even after controlling for other factors.

In pharmaceutical development, Eli Lilly’s Chorus model achieved a proof-of-concept success rate of 54% versus 29% under the traditional internal model, with a productivity improvement of 3 to 10 times over a comparable period. The model reached proof-of-concept in approximately 28 months at $6.3 million, roughly half the time and cost of a conventional early-phase decision point. Chorus allocated approximately 75% of its financial resources to external costs.

Internal capability remains necessary for evaluating and integrating outside knowledge. The barriers to external collaboration tend to originate internally. Chesbrough identified this pattern in MIT Sloan Management Review, and Deloitte confirmed it independently in that organizational silos and an institutional preference for self-reliance limit external engagement more than market or structural factors do.

 

What the research shows on search strategy

The open innovation literature, established by Chesbrough in 2003 and reviewed at its twenty-year mark in MIT Sloan Management Review, consistently finds that firms with broad and deep external search strategies are more innovative than those relying primarily on internal knowledge generation.

Laursen and Salter’s panel study confirmed this relationship and added an important qualification; returns are subject to diminishing limits. Organizations that spread external collaboration too thinly, without the internal absorptive capacity to evaluate and integrate outside knowledge, see the advantage erode. This is the basis for the hybrid model that practitioners consistently recommend – external specialists for niche and time-sensitive challenges, internal teams for core competencies and institutional continuity.

The Deloitte Survey of Innovation Excellence adds an organizational dimension. Approximately 40% of surveyed companies cite IP protection concerns as a limiting factor in external collaboration, and internal silos consistently rank among the top reported barriers. These are structural rather than strategic obstacles. They reflect how organizations are built, not how they have chosen to compete.

 

The cost structure of internal expertise

A separate dimension of the argument concerns resource allocation. The full cost of a full-time employee runs 25 to 40% above base salary when benefits, payroll taxes, equipment, and administrative overhead are included, according to data from the U.S. Small Business Administration. Bureau of Labor Statistics Employer Costs for Employee Compensation data confirms that private-sector benefits add approximately $0.42 for every dollar of wages paid.

For specialized or narrow domains, where the expertise is needed for a defined project rather than ongoing operations, the cost calculus shifts. External specialists reach full productivity in approximately 40 days at an average onboarding cost of $6,250, compared to roughly 206 days and $39,107 for a full-time hire when ramp time is accounted for.

The relevant question is not whether internal or external expertise is categorically preferable. It is whether the organization is making that choice deliberately or by default. BCG research on R&D portfolio governance found that only 23% of companies use stage-gate processes with clearly defined criteria for resource allocation decisions, and fewer than 40% report strong reliance on metrics for innovation governance.

 

A framework for decision-making

The literature points to a consistent framework, where activities that create competitive differentiation and require institutional continuity belong in-house. Activities that require niche expertise, cross-industry knowledge, or rapid deployment of specialized skills are candidates for external engagement.

Deloitte survey data indicates that approximately 42% of organizations are currently seeking to expand strategic ecosystem partnerships, with universities and academic researchers ranking among the most sought-after external partners. This is consistent with the broader trend Chesbrough identified at the twenty-year mark of open innovation, the model has moved from a theoretical framework to an operational assumption in the most competitive sectors.

The pharmaceutical sector’s structural shift is the clearest illustration. A 2018 analysis in the Journal of Translational Medicine found that 15 of 21 major pharmaceutical companies had adopted open innovation models for at least a portion of their pipeline. For companies in rapidly changing environments, the same analysis concluded, building specialized capabilities internally carries the risk of obsolescence before completion. External engagement is specifically designed to hedge that risk.

 

Implications for planning

External partnerships have historically been treated as a response to capability gaps, a resource of last resort when internal teams reach the boundary of their expertise. The evidence does not support this framing. The companies that benefit most from external collaboration are those that build it into their planning cycles as a standing budget line, not those that reach for it opportunistically.

For organizations structuring their innovation strategy, the practical implication is straightforward; identify the domains where specialized external expertise would reduce time-to-decision, improve the quality of the question being asked, or provide access to knowledge that would take years to build internally. Budget for those engagements explicitly. Measure them against the same criteria applied to internal R&D investments. 

 

How NotedSource approaches the problem

The practical barrier to external collaboration is rarely conviction. It is execution. Identifying qualified experts, verifying their relevance to a specific project, and managing the contracting and scheduling involved are operationally intensive in a way that discourages organizations from doing it systematically. 

NotedSource works with companies across every major industry, including Fortune 100 and Fortune 500 organizations, to handle that process end to end.

When a client brings a project, the first step is a scoping conversation to establish the pain points, the end deliverables, the timeline, and the level of expertise required. From there, NotedSource conducts a systematic literature review of publicly available information alongside internal tools to identify a shortlist of candidates whose backgrounds are genuinely aligned with the project, not just adjacent to it.

Each candidate on the shortlist is then interviewed directly against the project scope before any introduction to the client takes place. This step distinguishes the process from a directory search or a referral. The goal is to confirm, specifically, that the candidate can address the deliverables the client described. Once alignment is confirmed, NotedSource negotiates rates within the client’s budget, and handles contracts, payments, and scheduling.

The scope of work varies considerably. Projects range from single consulting calls and expert presentations to white paper development, report writing, RFP support, and fully funded R&D engagements. What stays consistent is the process – a structured intake, a research-backed identification methodology, direct candidate vetting, and full administrative support through to project completion.

The friction that keeps organizations from engaging external partners consistently is a process problem. NotedSource was built to solve it.

 

References

Itzkovich, Y. et al. (2022). External R&D collaborations and innovation output in high-tech firms. Journal of Innovation and Entrepreneurship, Springer Nature. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703404/

Chesbrough, H. (2020). Twenty Years of Open Innovation. MIT Sloan Management Review. https://sloanreview.mit.edu/article/twenty-years-of-open-innovation/

Guedj, I. et al. (2018). Virtual pharma and open innovation in drug development. Journal of Translational Medicine. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941640/

Deloitte. (2024). Survey of Innovation Excellence. https://www.deloitte.com/us/en/about/articles/survey-innovation-excellence.html

U.S. Bureau of Labor Statistics. (December 2025). Employer Costs for Employee Compensation. https://www.bls.gov/news.release/ecec.nr0.htm